Novel Drug Shows Activity in Prostate Cancer

VIENNA (MedPage Today) -- An investigational androgen receptor antagonist achieved partial response or stable disease after 12 weeks of therapy in almost all evaluable patients with castration-resistant prostate cancer, an initial clinical study showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/10/novel-drug-shows-activity-in-prostate.html